Antipsychotics for aggressive adolescents: Barriers to best practice

Elizabeth A. Pappadopulos, Sonja E. Siennick, Peter S. Jensen

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


In adolescents, antipsychotics are most often used to treat complex, comorbid conditions with core disruptive features. However, the literature guiding such practices is limited. Best practice guidelines bridging the gap between the evidence and clinical practice have been developed to promote the appropriate and safe use of antipsychotics in aggressive youths. Due to complex barriers that exist at the level of the physician, patient/family and organization, merely disseminating these guidelines will not likely change antipsychotic prescribing practices. Negative attitudes, time constraints, lack of staff training and resources, or adolescent/family nonadherence can impede the translation of best practice guidelines into routine practices. Efforts to implement best practice guidelines must address these barriers if changes in prescribing practices are to occur and be sustained.

Original languageEnglish (US)
Pages (from-to)85-98
Number of pages14
JournalExpert review of neurotherapeutics
Issue number1
StatePublished - Jan 1 2003


  • Adolescents
  • Aggression
  • Antipsychotic medications
  • Barriers
  • Best practice guidelines
  • Dissemination and implementation of practice guidelines

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)


Dive into the research topics of 'Antipsychotics for aggressive adolescents: Barriers to best practice'. Together they form a unique fingerprint.

Cite this